Cross-reactivity of Cryptococcal Antigen Lateral Flow Assay with Basidiomycetous Yeasts
Clicks: 12
ID: 319343
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
3.3
/100
12 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #96 of 159 articles by views in medical mycology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 159 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The cryptococcal antigen lateral flow assay (CrAg LFA) is a widely available point of care test for the diagnosis of cryptococcal meningitis. Although there have been some reports of cross-reactivity with Trichosporon species, the extent of cross-reactivity among basidiomycetous yeasts has not been widely explored. We tested a range of basidiomycete yeast isolates using a CrAg LFA to examine potential cross-reactivity, with positive results for all isolates belonging to Trichosporon and Naganishia species, and in some isolates of Cutaneotrichosporon, Filobasidium and Ustilago species. While these species rarely cause invasive infection, the potential for cryptococcal antigen cross-reactivity should be considered.
| Reference Key |
openalex_W7166685844
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | S Kidd, Catriona L Halliday |
| Journal | medical mycology |
| Year | 2026 |
| DOI |
10.1093/mmy/myag070
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.